Safe use of opioids in chronic noncancer pain

Teresa E. Dews, MD
Department of Pain Management, The Cleveland Clinic Foundation

Nagy Mekhail, MD, PhD
Chairman, Department of Pain Management, The Cleveland Clinic Foundation

Address: Teresa E. Dews, MD, Department of Pain Management, C25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Mekhail has indicated that he is on the speakers’ bureau of Pfizer, Merck, and Medtronic corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Teresa E. Dews, MD
Department of Pain Management, The Cleveland Clinic Foundation

Nagy Mekhail, MD, PhD
Chairman, Department of Pain Management, The Cleveland Clinic Foundation

Address: Teresa E. Dews, MD, Department of Pain Management, C25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Mekhail has indicated that he is on the speakers’ bureau of Pfizer, Merck, and Medtronic corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Teresa E. Dews, MD
Department of Pain Management, The Cleveland Clinic Foundation

Nagy Mekhail, MD, PhD
Chairman, Department of Pain Management, The Cleveland Clinic Foundation

Address: Teresa E. Dews, MD, Department of Pain Management, C25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Mekhail has indicated that he is on the speakers’ bureau of Pfizer, Merck, and Medtronic corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.